FR2357547A1 - Nouveaux derives de la benzo(g)isoquinoleine, leur preparation et leur application comme medicaments - Google Patents

Nouveaux derives de la benzo(g)isoquinoleine, leur preparation et leur application comme medicaments

Info

Publication number
FR2357547A1
FR2357547A1 FR7720814A FR7720814A FR2357547A1 FR 2357547 A1 FR2357547 A1 FR 2357547A1 FR 7720814 A FR7720814 A FR 7720814A FR 7720814 A FR7720814 A FR 7720814A FR 2357547 A1 FR2357547 A1 FR 2357547A1
Authority
FR
France
Prior art keywords
preparation
isoquinoleine
benzo
application
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7720814A
Other languages
English (en)
French (fr)
Other versions
FR2357547B1 (enExample
Inventor
Jean-Michel Bastian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH863276A external-priority patent/CH622783A5/de
Priority claimed from CH863176A external-priority patent/CH622782A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2357547A1 publication Critical patent/FR2357547A1/fr
Application granted granted Critical
Publication of FR2357547B1 publication Critical patent/FR2357547B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/08Aza-anthracenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7720814A 1976-07-06 1977-07-06 Nouveaux derives de la benzo(g)isoquinoleine, leur preparation et leur application comme medicaments Granted FR2357547A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH863276A CH622783A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives
CH863176A CH622782A5 (en) 1976-07-06 1976-07-06 Process for the preparation of novel hexahydrobenz[g]isoquinoline derivatives

Publications (2)

Publication Number Publication Date
FR2357547A1 true FR2357547A1 (fr) 1978-02-03
FR2357547B1 FR2357547B1 (enExample) 1980-02-15

Family

ID=25703556

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720814A Granted FR2357547A1 (fr) 1976-07-06 1977-07-06 Nouveaux derives de la benzo(g)isoquinoleine, leur preparation et leur application comme medicaments

Country Status (19)

Country Link
US (1) US4150136A (enExample)
JP (1) JPS537681A (enExample)
AT (1) AT366369B (enExample)
CA (1) CA1094561A (enExample)
DE (1) DE2728831A1 (enExample)
DK (1) DK285077A (enExample)
ES (2) ES460371A1 (enExample)
FI (1) FI65242C (enExample)
FR (1) FR2357547A1 (enExample)
GB (1) GB1582783A (enExample)
IE (1) IE45241B1 (enExample)
IL (1) IL52449A (enExample)
MY (1) MY8400058A (enExample)
NL (1) NL7707307A (enExample)
NZ (1) NZ184547A (enExample)
PH (1) PH14074A (enExample)
PT (1) PT66758B (enExample)
SE (2) SE7707445L (enExample)
SU (1) SU692559A3 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678791A (en) * 1985-05-07 1987-07-07 Pennwalt Corporation 6-phenyl-1,2-3,4,4a,5-6,10b-octahydrobenz(h)isoquinolines useful for treating depression

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453548A (fr) * 1964-10-01 1966-06-03 Ibm Circuits de contrôle de déviation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1453548A (fr) * 1964-10-01 1966-06-03 Ibm Circuits de contrôle de déviation

Also Published As

Publication number Publication date
IL52449A (en) 1981-09-13
FI771986A7 (enExample) 1978-01-07
SU692559A3 (ru) 1979-10-15
DE2728831A1 (de) 1978-01-19
PT66758A (fr) 1977-08-01
AT366369B (de) 1982-04-13
MY8400058A (en) 1984-12-31
SE7707445L (sv) 1978-01-07
NZ184547A (en) 1980-08-26
GB1582783A (en) 1981-01-14
NL7707307A (nl) 1978-01-10
CA1094561A (en) 1981-01-27
IE45241B1 (en) 1982-07-14
PH14074A (en) 1981-01-26
PT66758B (fr) 1979-03-12
SE8207394L (sv) 1982-12-23
FI65242C (fi) 1984-04-10
FI65242B (fi) 1983-12-30
SE8207394D0 (sv) 1982-12-23
ATA477577A (de) 1981-08-15
ES460371A1 (es) 1979-05-01
IL52449A0 (en) 1977-10-31
JPS537681A (en) 1978-01-24
US4150136A (en) 1979-04-17
IE45241L (en) 1978-01-06
FR2357547B1 (enExample) 1980-02-15
ES476889A1 (es) 1979-07-16
AU2677177A (en) 1979-01-11
DK285077A (da) 1978-01-07

Similar Documents

Publication Publication Date Title
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2373513A1 (fr) Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments
FR2430419A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2387954A1 (fr) Derives de mercaptoalkylsulfonylproline et composes apparentes, et leur utilisation comme medicaments
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2379533A1 (fr) Tetrazolylcarbamoylquinoleines utilisables comme medicaments et leur preparation
FR2378781A1 (fr) Nouveaux derives d'alcaloides de l'ergot de seigle, leur preparation et leur application comme medicaments
FR2401160A1 (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
FR2378015A1 (fr) Nouveaux derives de la benzo(f)isoquinoleine, leur preparation et leur application comme medicaments
FR2379538A1 (fr) Nouveaux derives d'oxadiazolopyrimidine, leur preparation et leur application en tant que medicaments
FR2401139A2 (fr) Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2379532A1 (fr) Nouveaux derives de l'acide oxamique, leur preparation et leur application comme medicaments
FR2392011A1 (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
FR2359116A1 (fr) N-alkyldiphenylamines
FR2432506A1 (fr) Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments
FR2366289A1 (fr) Nouveaux derives de l'imidazo(5,1-a)isoquinoleine, leur preparation et leur application comme medicaments
FR2396748A1 (fr) Nouveaux derives de prostaglandine, leur preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
ST Notification of lapse